← Back to all trials
Completed
NCT07749690
Mental Rotation and Motor Imagery Training in Multiple Sclerosis
Conditions: Relapsing Remitting MS (RRMS)
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: NA
Enrollment: 54
Sponsor: Abant Izzet Baysal University
Location: Abant Izzet Baysal University Faculty of Health Science Bolu
Summary
This randomized controlled trial investigated the effects of sequential laterality, motor imagery, and mental rotation training in individuals with relapsing-remitting multiple sclerosis. Both groups received conventional physiotherapy, while the intervention group received structured cognitive-motor training and the control group received active visual-attention training.
Eligibility Criteria
Inclusion Criteria:
* Diagnosed with definite relapsing-remitting multiple sclerosis by a neurologist according to the revised McDonald criteria
* Not experiencing an acute MS relapse
* Mini Mental State Examination score ≥24
* No clinical MS relapse within the previous 3 months
* No corticosteroid treatment for an MS relapse within the previous 3 months
* Expanded Disability Status Scale score between 1.5 and 6.0
* Modified Ashworth Scale score ≤2
* Sufficient communication ability to understand visual and verbal instructions and follow the training protocol
* Able to attend at least 80% of the planned sessions
* Able to complete the Movement Imagery Questionnaire-3
Exclusion Criteria:
* Any medication change within the previous 3 months
* Uncorrected severe visual or hearing impairment
* A communication disorder preventing the perception of or response to the visual and verbal stimuli used in the study
* Participation in another structured upper-extremity rehabilitation program or interventional study during the study period
* Presence of an additional neurological disorder
* Advanced sensory loss or proprioceptive impairment that could affect participation in the intervention
* Botulinum toxin injection within the previous 3 months
Source: ClinicalTrials.gov (NCT07749690). StuddyBuddy aggregates publicly available trial information.